Pharma Mar (OTCMKTS:PHMMF) Sets New 1-Year High – Here’s Why

Pharma Mar, S.A. (OTCMKTS:PHMMF) hit a new 52-week high during mid-day trading on Wednesday . The company traded as high as $75.00 and last traded at $75.00, with a volume of 0 shares traded. The stock had previously closed at $75.00.

Wall Street Analysts Forecast Growth

Separately, Chardan Capital upgraded Pharma Mar to a “strong-buy” rating in a report on Thursday, August 1st.

Pharma Mar Stock Performance

The stock has a fifty day moving average of $65.97 and a 200-day moving average of $45.80. The company has a quick ratio of 2.01, a current ratio of 2.55 and a debt-to-equity ratio of 0.14.

About Pharma Mar

Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.